Preclinical Toxicity of AZD7969
Open Access
- 16 October 2014
- journal article
- research article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 43 (3), 384-399
- https://doi.org/10.1177/0192623314544468
Abstract
AZD7969 is a potent inhibitor of glycogen synthase kinase 3 (GSK3β), which is a multifunctional serine/threonine kinase that negatively regulates the Wnt/β-catenin signaling pathway. Treatment of rats and dogs with AZD7969 for periods of up to 4 weeks resulted in a number of changes, the most significant of which was a dose-dependent, and treatment-related, increase in proliferation in a number of tissues that was thought to arise from derepression of Wnt/β-catenin signaling in the stem cell compartment. Phenotypically, this resulted in hyperplasia that either maintained normal tissue architecture in the gastrointestinal tract, liver, kidney, and adrenals or effaced normal tissue architecture within the bones, incisor teeth, and femorotibial joint. In addition to these changes, we noted a treatment-related increase in iron loading in the liver and proximal small intestines. This off-target effect was robust, potent, and occurred in both dogs and rats suggesting that AZD7969 might be a useful tool compound to study iron storage disorders in the laboratory.Keywords
This publication has 54 references indexed in Scilit:
- Glycogen Synthase Kinase-3 Inhibition Promotes Proliferation and Neuronal Differentiation of Human-Induced Pluripotent Stem Cell-Derived Neural ProgenitorsStem Cells and Development, 2012
- Wnt/β-Catenin Signaling in Development and DiseaseCell, 2006
- Wnt signaling: complexity at the surfaceJournal of Cell Science, 2006
- Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in miceProceedings of the National Academy of Sciences of the United States of America, 2005
- Regulation of Protein Kinase D During Differentiation and Proliferation of Primary Mouse KeratinocytesJournal of Investigative Dermatology, 2005
- β-Catenin Is Dispensable for Hematopoiesis and LymphopoiesisThe Journal of Experimental Medicine, 2004
- Effects of a Novel Glycogen Synthase Kinase-3 Inhibitor on Insulin-Stimulated Glucose Metabolism in Zucker Diabetic Fatty (fa/fa) RatsDiabetes, 2002
- Glycogen synthase kinase 3: an emerging therapeutic targetTrends in Molecular Medicine, 2002
- Wnt Signaling to β-Catenin Involves Two Interactive ComponentsOnline Journal of Public Health Informatics, 2000
- Glycogen Synthase Kinase‐3 from Rabbit Skeletal MuscleJBIC Journal of Biological Inorganic Chemistry, 1980